Literature DB >> 11900835

Rapid evolution of two discrete regions of the caprine arthritis-encephalitis virus envelope surface glycoprotein during persistent infection.

Isidro Hötzel1, Nancy Kumpula-McWhirter, William P Cheevers.   

Abstract

Five major regions of sequence diversity between strains (V1-V5) have been described in the caprine arthritis-encephalitis lentivirus (CAEV) envelope surface unit glycoprotein (SU). To determine which of these variable regions is important in persistent infection in vivo, we evaluated SU sequence diversity in five neutralization variants from two goats and proviral DNA from five additional goats infected with CAEV-63 for up to 7 years. Overall amino acid sequence divergence in the SU encoded by provirus and neutralization variants compared to parental CAEV-63 ranged from 1.1 to 4%. However, most of the amino acid substitutions and all of the deletions and insertions were present in two discrete regions designated HV1 and HV2. The HV2 region was variable in all neutralization variants and provirus sequences from most animals. This region overlapped the V4 domain of CAEV SU and the neutralization domain of the closely related ovine maedi-visna lentivirus. HV1 was located in a region of SU strictly conserved in all small ruminant lentivirus strains except CAEV-63. This region only varied in a subset of neutralization variants and proviruses, all derived from goats with arthritis. In contrast, sequences in the V1,V2,V3, and V5 regions were stable in neutralization variants and proviruses from infected goats, indicating that sequence diversity between strains in these regions is not due to selection of variants in persistently infected animals. Our results define two discrete regions of CAEV SU that undergo rapid sequence variation in persistently infected goats which may have important roles in virus-host interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900835     DOI: 10.1016/s0168-1702(01)00421-x

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Domain Organization of Lentiviral and Betaretroviral Surface Envelope Glycoproteins Modeled with AlphaFold.

Authors:  Isidro Hötzel
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

2.  Molecular Characterization of Small Ruminant Lentiviruses Isolated from Polish Goats with Arthritis.

Authors:  Monika Olech; Anna Kycko; Jacek Kuźmak
Journal:  Viruses       Date:  2022-03-31       Impact factor: 5.818

3.  Caprine arthritis-encephalitis virus envelope surface glycoprotein regions interacting with the transmembrane glycoprotein: structural and functional parallels with human immunodeficiency virus type 1 gp120.

Authors:  Isidro Hötzel; William P Cheevers
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses.

Authors:  J D Trujillo; N M Kumpula-McWhirter; K J Hötzel; M Gonzalez; W P Cheevers
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Demonstration of coinfection with and recombination by caprine arthritis-encephalitis virus and maedi-visna virus in naturally infected goats.

Authors:  Giuliano Pisoni; Giuseppe Bertoni; Maria Puricelli; Marina Maccalli; Paolo Moroni
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

6.  Molecular Characterization of Small Ruminant Lentiviruses of Subtype A5 Detected in Naturally Infected but Clinically Healthy Goats of Carpathian Breed.

Authors:  Monika Olech; Jacek Kuźmak
Journal:  Pathogens       Date:  2020-11-26

7.  Molecular Characterization of Small Ruminant Lentiviruses in Polish Mixed Flocks Supports Evidence of Cross Species Transmission, Dual Infection, a Recombination Event, and Reveals the Existence of New Subtypes within Group A.

Authors:  Monika Olech; Jacek Kuźmak
Journal:  Viruses       Date:  2021-12-16       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.